Citation Impact
Citing Papers
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
2004 StandoutScience
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
Targeted Replacement of Hypoxia-Inducible Factor-1α by a Hypoxia-Inducible Factor-2α Knock-in Allele Promotes Tumor Growth
2005
Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature
2006
Concordant Regulation of Gene Expression by Hypoxia and 2-Oxoglutarate-dependent Dioxygenase Inhibition
2006 StandoutNobel
Biology of angiogenesis in tumors of the gastrointestinal tract
2003
The Vascular Endothelial Growth Factor Receptor Kdr/Flk–1 Is A Major Regulator of Malignant Ascites Formation in the Mouse Hepatocellular Carcinoma Model
2001
Inflammation and cancer
2002 StandoutNature
HIF-1α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas
2005 StandoutNobel
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
Molecular pathogenesis of human hepatocellular carcinoma
2002
Genes that mediate breast cancer metastasis to the brain
2009 StandoutNature
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
2007 StandoutNature
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium
2007 StandoutNobel
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 StandoutNature
Cancer Metastasis: Building a Framework
2006 Standout
Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: Contrasting, overlapping and compensatory functions
2009
Disseminated Single Tumor Cells as Detected by Real-Time Quantitative Polymerase Chain Reaction Represent a Prognostic Factor in Patients Undergoing Surgery for Colorectal Cancer
2002
Ranibizumab for Neovascular Age-Related Macular Degeneration
2006 Standout
A new mathematical model for relative quantification in real-time RT-PCR
2001 Standout
Review: Hydrogels for cell immobilization
2000
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
DETECTION OF DISSEMINATED TUMOR CELLS IN PERIPHERAL BLOOD
2005
When Checkpoints Fail
1997 StandoutNobel
Emerging roles of proteases in tumour suppression
2007
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1
2006 StandoutNobel
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
1997 Standout
Insulin-like Growth Factor 1 Induces Hypoxia-inducible Factor 1-mediated Vascular Endothelial Growth Factor Expression, Which is Dependent on MAP Kinase and Phosphatidylinositol 3-Kinase Signaling in Colon Cancer Cells
2002 StandoutNobel
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Inflammation and Colon Cancer
2010 Standout
Viral hepatitis and liver cancer: the case of hepatitis C
2006
Hypoxia Inhibits G1/S Transition through Regulation of p27 Expression
2001 StandoutNobel
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer
2007 Standout
Molecular and biological properties of vascular endothelial growth factor
1999
Multifactorial analysis of p53 alteration in human cancer: A review
1994
The MDM2 gene amplification database
1998
Human papillomavirus types 16 and 18 in esophagus squamous cell carcinoma: a meta-analysis
2013
NMR structure of a complex between MDM2 and a small molecule inhibitor
2004
Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria
2003
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
2002 Standout
Imaging Dynamic Redox Changes in Mammalian Cells with Green Fluorescent Protein Indicators
2004 StandoutNobel
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
2004 Standout
Analysis of the inhibition of mammalian thioredoxin, thioredoxin reductase, and glutaredoxin by cis-diamminedichloroplatinum (II) and its major metabolite, the glutathione-platinum complex
2001
Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α
1999 StandoutNobel
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
2003 StandoutNature
Role of a novel oncogenic protein, gankyrin, in hepatocyte proliferation
2003
Hypoxia-inducible Factor-1 Deficiency Results in Dysregulated Erythropoiesis Signaling and Iron Homeostasis in Mouse Development
2006 StandoutNobel
Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma
2003
Human DNA Damage Checkpoint Protein hRAD9 Is a 3′ to 5′ Exonuclease
2000 StandoutNobel
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Vascular endothelial growth factor receptor‐1 promotes migration and invasion in pancreatic carcinoma cell lines
2005
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
Angiogenesis as a therapeutic target
2005 StandoutNature
Circulating Cancer Cells in Peripheral Blood
2000
Defects in the Ubiquitin Pathway Induce Caspase-independent Apoptosis Blocked by Bcl-2
1998 StandoutNobel
Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays
2000 Standout
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis.
2002
Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma.
1998
Hydrogels for Tissue Engineering
2001 Standout
The thioredoxin redox inhibitors 1-methylpropyl 2-imidazolyl disulfide and pleurotin inhibit hypoxia-induced factor 1alpha and vascular endothelial growth factor formation.
2003
Cell Cycle Control and Cancer
1994 StandoutScienceNobel
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and Therapy
2002
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
1998 StandoutScience
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
ZD4190: an orally active inhibitor of vascular endothelial growth factor signaling with broad-spectrum antitumor efficacy.
2000
Global cancer statistics, 2012
2015 Standout
Integrating Genetic Approaches into the Discovery of Anticancer Drugs
1997 StandoutScienceNobel
Macrophage Elastase (Matrix Metalloproteinase-12) Suppresses Growth of Lung Metastases
2006
Cell Cycle Checkpoints: Preventing an Identity Crisis
1996 StandoutScience
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Works of M Imamura being referenced
Hematogenous Spreading of Hepatocellular Carcinoma Cells: Possible Participation in Recurrence in the Liver
1997
In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis
1998
Expression of vascular endothelial growth factor, matrix metalloproteinase-9 and E-cadherin in the process of lymph node metastasis in oesophageal cancer
1999
Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer, and its relationship to angiogenesis
1998
Cytokeratin 20 mRNA in peripheral venous blood of colorectal carcinoma patients
1998
Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer
1998
Expression of thioredoxin and glutaredoxin, redox-regulating proteins, in pancreatic cancer.
2000
Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor
1996
TGF-alpha as well as VEGF, PD-ECGF and bFGF contribute to angiogenesis of esophageal squamous cell carcinoma.
2000
Enhanced expression of multiple protein tyrosine phosphatases in the regenerating mouse liver: isolation of PTP-RL10, a novel cytoplasmic-type phosphatase with sequence homology to cytoskeletal protein 4.1.
1995
p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma.
1995
Mouse macrophage metalloelastase gene transfer into a murine melanoma suppresses primary tumor growth by halting angiogenesis.
2000
Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas.
1993
Improved insulin release from a bioartificial pancreas using mesh-reinforced polyvinyl alcohol hydrogel tube: immobilization of islets in agarose gel.
1994
Overexpression of Matrix Metalloproteinase 9 Gene in Hepatocellular Carcinoma With Invasive Potential
1996
sFlt-1 gene-transfected fibroblasts: a wound-specific gene therapy inhibits local cancer recurrence.
2001